Abiopharma

🔍 Accel Growth Fund IV L.P. (Executive)

Company: Ethos Technologies Inc. (LIFE)

Report Date: 2026-08-11

Detailed Transactions and Holdings:

• Acquired 711,900 shares of Class A Common Stock (Direct)
  Date: 2026-08-11 | Code: C | equity_swap_involved: 0 | shares_owned_after: 711,900.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 34,050 shares of Class A Common Stock (Direct)
  Date: 2026-08-11 | Code: C | equity_swap_involved: 0 | shares_owned_after: 34,050.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 4,050 shares of Class A Common Stock (Direct)
  Date: 2026-08-11 | Code: C | equity_swap_involved: 0 | shares_owned_after: 4,050.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 711,900 shares of Class A Common Stock (Direct)
  Date: 2026-08-11 | Code: J | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F2
• Sold 34,050 shares of Class A Common Stock (Direct)
  Date: 2026-08-11 | Code: J | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F3
• Sold 4,050 shares of Class A Common Stock (Direct)
  Date: 2026-08-11 | Code: J | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F4
• Sold 711,190 shares of Class B Common Stock (Derivative)
  Date: 2026-08-11 | Code: C | equity_swap_involved: 0 | shares_owned_after: 4,373,831.00 | transaction_form_type: 4 | Footnotes: F1, F1, F1
• Sold 34,050 shares of Class B Common Stock (Derivative)
  Date: 2026-08-11 | Code: C | equity_swap_involved: 0 | shares_owned_after: 209,205.00 | transaction_form_type: 4 | Footnotes: F1, F1, F1
• Sold 4,050 shares of Class B Common Stock (Derivative)
  Date: 2026-08-11 | Code: C | equity_swap_involved: 0 | shares_owned_after: 24,879.00 | transaction_form_type: 4 | Footnotes: F1, F1, F1

Footnotes:

• F1: Each share of Class B Common Stock is convertible at the option of the holder thereof into one share of Class A Common Stock and otherwise in accordance with the terms of the Issuer's Certificate of Incorporation. The securities have no expiration date.
• F2: On August 11, 2026, Accel Growth Fund IV L.P. distributed, for no consideration, 711,900 shares of Class A common stock of the Issuer (the "Accel Growth IV Shares") to its limited partners and to Accel Growth Fund IV Associates L.L.C., the general partner of Accel Growth Fund IV L.P., representing each such partner's pro rata interest in such Accel Growth IV Shares. On the same date, Accel Growth Fund IV Associates L.L.C. distributed, for no consideration, the Accel Growth IV Shares it received in the distribution by Accel Growth Fund IV L.P. to its members, representing each such member's pro rata interest in such Accel Growth IV Shares. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and 16a-9 of the Securities Exchange Act of 1934, as amended.
• F3: On August 11, 2026, Accel Growth Fund Investors 2016 L.L.C. distributed, for no consideration, 34,050 shares of Class A common stock of the Issuer to its members, representing each such member's pro rata interest in such shares. The aforementioned distribution was made in accordance with the exemptions afforded by Rules 16a-13 and 16a-9 of the Securities Exchange Act of 1934, as amended.
• F4: On August 11, 2026, Accel Growth Fund IV Strategic Partners L.P. distributed, for no consideration, 4,050 shares of Class A common stock of the Issuer (the "Accel Growth IV SP Shares") to its limited partners and to Accel Growth Fund IV Associates L.L.C., the general partner of Accel Growth Fund IV Strategic Partners L.P., representing each such partner's pro rata interest in such Accel Growth IV SP Shares. On the same date, Accel Growth Fund IV Associates L.L.C. distributed, for no consideration, the Accel Growth IV SP Shares it received in the distribution by Accel Growth Fund IV Strategic Partners L.P. to its members, representing each such member's pro rata interest in such Accel Growth IV SP Shares. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and 16a-9 of the Securities Exchange Act of 1934, as amended.